Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

Back to Item »

FDA Green Lights Therapies from Merck & Co., GSK, Baxter, and CSL Behring

Approvals include congenital Protein C deficiency treatment, addition to a label, accelerated dosing for hepatitis combo vaccine, and a type 2 diabetes drug.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »